1. Global prevalence and incidence estimates of selected curable STDs;Gerbase;Sex Transm Inf,1998
2. Zaneveld LJD, Anderson DJ, Whaley KJ. Barrier methods and mucosal immunological approaches. Part I. Barrier methods. In: Harrison PF, Rosenfield A, editors. Contraceptive research and development. Looking to the future. Washington, DC: National Academic Press, 1996. p. 430–73.
3. Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro;Hicks;Lancet,1985
4. Studies on development of a vaginal preparation providing both prophylaxis against venereal disease, other genital infections and contraception. II. In vitro effect of contraceptive preparations on Treponema pallidum and Neisseria gonorrhoeae;Singh;Br J Vener Dis,1972
5. Zaneveld LJD. Vaginal contraception since 1984: chemical agents and barrier devices. In: Van Look, PFA, Perez-Palacios, G, editors. Contraceptive research and development. 1984 to 1994: the road from Mexico City to Cairo and beyond. Delhi: Oxford University Press, 1994. p. 430–73.